FDA PMA FDA Class 2 Approved 🇺🇸 United States

Intervertebral Fusion Device With Bone Graft, Lumbar

PMA: P970015 · Supplement: S010 · Decision Sep 28, 2000
Classifications
1
FEI Numbers
422
Registration Numbers
422

Basic Information

Device Name
Intervertebral Fusion Device With Bone Graft, Lumbar
Trade Name
LORDOTEC(TM) TAPERED FUSION DEVICE
PMA Number
P970015
Supplement Number
S010
Device Class
FDA Class 2
Product Code
MAX
Generic Name
Intervertebral fusion device with bone graft, lumbar
Regulation Number
888.3080
Medical Specialty
Orthopedic
Advisory Committee
Orthopedic
Decision
Approved
Decision Code
APPR
Decision Date
September 28, 2000
Date Received
November 24, 1999
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR A TAPERED VERSION OF THE INTERFIX(TM) THREADED FUSION DEVICE. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME LT-CAGE(TM) TAPERED FUSION DEVICE AND IS INDICATED FOR SPINAL FUSION PROCEDURES IN SKELETALLY MATURE PATIENTS WITH DEGENERATIVE DISC DISEASE (DDD) AT ONE LEVEL FROM L2-S1. DDD IS DEFINED AS DISCOGENIC BACK PAIN WITH DEGENERATION OF THE DISC CONFIRMED BY PATIENT HISTORY AND RADIOGRAPHIC STUDIES. THESE DDD PATIENTS MAY ALSO HAVE UP TO GRADE I SPONDYLOLISTHESIS OR RETROLISTHESIS AT THE INVOLVED LEVEL. LT-CAGE(TM) IMPLANTS ARE TO BE USED WITH AUTOGENOUS BONE GRAFT AND IMPLANTED VIA A LAPAROSCOPIC OR AN OPEN ANTERIOR APPROACH. PATIENTS RECEIVING THE LT-CAGE(TM) LUMBAR TAPERED FUSION DEVICE SHOULD HAVE HAD AT LEAST SIX MONTHS OF NONOPERATIVE TREATMENT PRIOR TO TREATMENT WITH THE LT-CAGE(TM)

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MAX Intervertebral Fusion Device With Bone Graft, Lumbar